June 12, 2019
- CDER Conversation: Ensuring That Standardization Does Not Impede Biological Product Innovation
- FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA Drug Shortages
- Buspirone HCl Tablets (Updated - Currently in Shortage)
- Carisoprodol Tablets, USP (Updated - Currently in Shortage)
- Chlorpheniramine Maleate; Hydrocodone Bitartrate; Pseudoephedrine Hydrochloride Oral Solution (New - Discontinuation)
- Dexrazoxane Injection (Updated - Currently in Shortage)
- Dextrose 5% Injection Bags (Updated - Currently in Shortage)
- Guanfacine Hydrochloride Tablets (New - Currently in Shortage)
- Levetiracetam Immediate-Release Oral Tablets, USP (Updated - Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated - Currently in Shortage)
- Sterile Talc Powder (Updated - Resolved)
- Sterile Water (Updated - Currently in Shortage)
- Valsartan Tablets (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario